Latest news

Thumbnail image for EU regulators expand Praluent’s label

EU regulators expand Praluent’s label

European regulators have approved a new indication for Regeneron and Sanofi’s Praluent, allowing its use to cut cardiovascular risk in adults with established atherosclerotic CV disease (ASCVD).

18th March 2019

Thumbnail image for CCGs failing to demonstrate value for money

CCGs failing to demonstrate value for money

As many as 38% of NHS bodies such as clinical commissioning groups (CGCs) and hospital trusts are failing to show that the money they spend is good value, according to a report by the Public Accounts Committee.

15th March 2019

Thumbnail image for Study warns of disinfectant use in hospitals

Study warns of disinfectant use in hospitals

A new study has warned that the use of disinfectants to clean and control infections in hospitals should be regulated in the same way that prescribing antibiotics is, to help combat antimicrobial resistance.

15th March 2019

Thumbnail image for New lung cancer indication for Keytruda combo OK’d in EU

New lung cancer indication for Keytruda combo OK’d in EU

MSD’s anti-PD-1 therapy Keytruda has been approved for use in combination with carboplatin and either paclitaxel or nab-paclitaxel for first-line treatment of adults with metastatic squamous non-small cell lung cancer (NSCLC).

14th March 2019

Thumbnail image for EC extends license for Roche/Chugai’s Hemlibra

EC extends license for Roche/Chugai’s Hemlibra

The European Commission has approved Roche and Chugai Pharma UK’s Hemlibra for the prevention of bleeding episodes in people with severe haemophilia A without factor VIII inhibitors, expanding the drug’s treatment scope.

14th March 2019

Previous  --   5 6 7 8 9 10 11 12 13 14   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download